Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-β Production by Epidermal Keratinocytes during Skin Injury

Immunity. 2016 Jul 19;45(1):119-30. doi: 10.1016/j.immuni.2016.06.021.

Abstract

Type 1 interferons (IFNs) promote inflammation in the skin but the mechanisms responsible for inducing these cytokines are not well understood. We found that IFN-β was abundantly produced by epidermal keratinocytes (KCs) in psoriasis and during wound repair. KC IFN-β production depended on stimulation of mitochondrial antiviral-signaling protein (MAVS) by the antimicrobial peptide LL37 and double stranded-RNA released from necrotic cells. MAVS activated downstream TBK1 (TANK-Binding Kinase 1)-AKT (AKT serine/threonine kinase 1)-IRF3 (interferon regulatory factor 3) signaling cascade leading to IFN-β production and then promoted maturation of dendritic cells. In mice, the production of epidermal IFN-β by LL37 required MAVS, and human wounded and/or psoriatic skin showed activation of MAVS-associated IRF3 and induction of MAVS and IFN-β gene signatures. These findings show that KCs are an important source of IFN-β and MAVS is critical to this function, and demonstrates how the epidermis triggers unwanted skin inflammation under disease conditions.

MeSH terms

  • Adaptor Proteins, Signal Transducing / genetics
  • Adaptor Proteins, Signal Transducing / metabolism
  • Animals
  • Antimicrobial Cationic Peptides
  • Cathelicidins / genetics
  • Cathelicidins / metabolism*
  • Cell Differentiation
  • Cells, Cultured
  • Dendritic Cells / physiology*
  • Epidermis / pathology*
  • Humans
  • Interferon-beta / metabolism
  • Keratinocytes / immunology*
  • Mice
  • Mice, Knockout
  • Mitochondria / metabolism*
  • Psoriasis / immunology*
  • RNA, Small Interfering / genetics
  • Signal Transduction
  • Wound Healing
  • Wounds and Injuries / immunology*

Substances

  • Adaptor Proteins, Signal Transducing
  • Antimicrobial Cationic Peptides
  • Cathelicidins
  • IPS-1 protein, mouse
  • RNA, Small Interfering
  • Interferon-beta